Company / Current Assets
MUSTANG BIO, INC. Current Assets History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$63.1M
FY2019
5-year range
$27.5M / $63.1M
FY2016-FY2019
Trend
+79.5%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $61M to $63M over the past 2 years.
Based on SEC 10-K filings.
$63M in FY2019 with a 3-year CAGR of +31.9%.
Improved from $61M to $63M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +31.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +31.9%, indicating consistent growth.
- In FY2019, current assets increased 79.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.37 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $63.1M | +79.5% |
| FY2018 | $35.1M | -42.8% |
| FY2017 | $61.4M | +123.1% |
| FY2016 | $27.5M | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026